We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection

By LabMedica International staff writers
Posted on 09 Sep 2022
Print article
Image: The global PCR and real-time PCR testing market is expected to approach USD 25 billion in 2026 (Photo courtesy of Pexels)
Image: The global PCR and real-time PCR testing market is expected to approach USD 25 billion in 2026 (Photo courtesy of Pexels)

The polymerase chain reaction (PCR) and real-time polymerase chain reaction testing market consists of sales of PCR and real-time PCR testing services and related products. The real-time RT-PCR technique is a highly sensitive and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours. Real-time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube. With the onset of chronic diseases, there is focus on detecting the cause of the disease to decrease its onset on people, for drug discovery and for starting the appropriate treatment at the appropriate time, which enables faster cure, saves maximum lives and decreases after-effects.

Early detection plays a key role in treating COVID-19 patients. Real-time RT-PCR is considered to be the most accurate method available for the detection of coronavirus. The RT-PCR test is the standard test for coronavirus and is used for its high sensitivity, which enables it to detect early infection. This has created a huge demand for PCR testing kits. Thus, the need for early detection of COVID-19 is driving the growth of the PCR and real-time PCR testing market. Additionally, most companies are coming up with real-time RT-PCR tests for coronavirus, thus contributing to the market growth. The global PCR and real time PCR testing market is expected to grow at a CAGR of 6.2% from USD 18.5 billion in 2021 to USD 19.64 billion in 2022 and further grow to USD 24.61 billion in 2026 at a CAGR of 5.8%. In 2021, Asia Pacific was the largest PCR and real-time PCR testing market, followed by Western Europe.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

The players operating in the PCR and real-time PCR testing market manufacture, develop, or deploy related devices, reagents, and services, to detect and measure DNA (or RNA) in a sample. PCR and real-time PCR testing find applications in cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The main products involved in PCR and real-time PCR testing are consumables and reagents, instruments, and software and services. The technologies involved in PCR and real-time PCR testing are quantitative PCR and digital PCR that find various applications such as clinical diagnostics, life science research, industrial applications, and others. The need for early detection of diseases is expected to continue driving the global PCR and real time PCR testing market. The players operating in the PCR and RT PCR testing market are coming up with new test kits and systems for the diagnosis of diseases. However, the development of alternative technologies such as CRISPR is expected to hinder market growth.

Related Links:
Research and Markets 

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Sekisui Diagnostics UK Ltd.